ARCHIVES

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Letter: Boy Has Little Chance At Cure Without Proven Treatments.

February 11, 2000

In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC

July 2, 1999

New Health Bills Could Affect Cancer Program

February 9, 1979

OSI Underestimated Magnitude Of Gallo Case: Hadley

February 3, 1995

In Brief: Senate committee Oks Another Cigarette Tax Hike; NCI Seeking Cancer Control Science Head

August 1, 1986

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006